AKTX

Akari Therapeutics (AKTX)

About Akari Therapeutics (AKTX)

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.

Details

Daily high

$8.03

Daily low

$7.41

Price at open

$7.98

52 Week High

$49.60

52 Week Low

$3.02

Market cap

9.2M

Dividend yield

0.00%

Volume

12,406

Avg. volume

37,256

P/E ratio

-.03

Akari Therapeutics News